Submitting OIG:
Report Description:
Congress created the 340B Drug Pricing Program to assist providers serving vulnerable patient populations by allowing them to purchase outpatient drugs at discounted prices. For drugs dispensed to Medicare Part D beneficiaries for payment under the Part D program, manufacturers may pay rebates based on rebate agreement terms negotiated between the manufacturers and the Part D prescription drug plan sponsors or their pharmacy benefit managers. Rebate agreement terms may prevent manufacturers from paying rebates for Part D prescriptions filled at 340B contract pharmacies.
Date Issued:
Monday, July 1, 2019
Agency Reviewed / Investigated:
Submitting OIG-Specific Report Number:
A-03-16-00002
Component, if applicable:
Centers for Medicare & Medicaid Services
Location(s):
Agency-Wide
Type of Report:
Audit
View Document:
Attachment | Size |
---|---|
31600002.pdf | 657.84 KB |
Additional Details Link: